Equities

Ste Promotion Pharmaceutique du Maghreb SA

PRO:CAS

Ste Promotion Pharmaceutique du Maghreb SA

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (MAD)873.00
  • Today's Change0.00 / 0.00%
  • Shares traded90.00
  • 1 Year change-7.32%
  • Beta0.1437
Data delayed at least 20 minutes, as of Nov 13 2024 13:32 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

As of last trade Ste Promotion Pharmaceutique du Maghreb SA (PRO:CAS) traded at 873.00, 0.00% above its 52-week low of 873.00, set on Nov 13, 2024.
52-week range
Today
873.00Nov 13 20241,150.00Sep 30 2024
Open873.00
High873.00
Low873.00
Bid885.00
Offer919.00
Previous close873.00
Average volume63.80
Shares outstanding1.00m
Free float58.80k
P/E (TTM)15.67
Market cap873.00m MAD
EPS (TTM)55.72
MAD
Annual div (ADY)--
Annual div yield (ADY)4.58%
Div ex-dateSep 11 2023
Div pay-dateSep 20 2023
Data delayed at least 20 minutes, as of Nov 13 2024 13:32 GMT.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.